Viveve Medical Inc
Change company Symbol lookup
Select an option...
VIVE Viveve Medical Inc
GILT Gilat Satellite Networks Ltd
BRK.A Berkshire Hathaway Inc
AHTYX American Beacon AHL TargetRisk Fund Y Class
HMCBF Home Capital Group Inc
FELE Franklin Electric Co Inc
MKTX Marketaxess Holdings Inc
COCP Cocrystal Pharma Inc
BKYI BIO-Key International Inc
ASTC Astrotech Corp

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.


Last Trade
-0.0389 (-5.65%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:



7 providers
March 26, 2020
Viveve Announces Clearance of Next Generation 2.0 System in Taiwan

Viveve 2.0 cryogen-cool monopolar radiofrequency technology and consumable treatment tips are now available in the U.S., China, Hong Kong, South Korea, Taiwan and more than 30 European countries ENGLEWOOD, CO / ACCESSWIRE / March 26, 2020 / Viveve...(Accesswire)

March 19, 2020
Viveve Reports Full Year 2019 Financial Results

ENGLEWOOD, CO / ACCESSWIRE / March 19, 2020 / Viveve Medical Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the year ended December 31, 2019. The Company will provide a...(Accesswire)

Viveve Medical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 19, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 19, 2020 at 5:00 PM Eastern Time. (Accesswire)

March 12, 2020
Viveve Announces Completion of VIVEVE II Pivotal FDA Clinical Trial for Improvement of Sexual Function

Unblinded top-line results of the 12-month U.S. study anticipated in April If positive, results may support a 2020 marketing application for an expanded U.S. indication for improvement of sexual function in women (Accesswire)

March 06, 2020
Viveve to Host Conference Call to Provide Corporate Update and Year-End 2019 Financial Results on March 19, 2020

ENGLEWOOD, CO / ACCESSWIRE / March 6, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will provide a corporate update and report its year-end 2019 financial results...(Accesswire)

March 04, 2020
Viveve Completes Enrollment in Short-Term Feasibility Study for Stress Urinary Incontinence

Three-arm study compares Viveve's Cryogen-cooled Monopolar Radiofrequency (CMRF) treatment and cryogen-only sham to inert sham treatmentTopline results anticipated in third quarter 2020 ENGLEWOOD, CO / ACCESSWIRE / March 4, 2020 / Viveve Medical...(Accesswire)

January 14, 2020
Viveve Initiates Enrollment of its Short-Term Feasibility Study in Stress Urinary Incontinence

Three-arm, three-month study will compare Viveve's cryogen-cooled monopolar radiofrequency (CMRF) treatment and cryogen-only sham to inert sham treatment ENGLEWOOD, CO / ACCESSWIRE / January 14, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical...(Accesswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.